Annals of internal medicine
-
Multicenter Study
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain. ⋯ Bayer Hispania.
-
Clostridioides difficile infection (CDI) is a risk factor for bloodstream infection (BSI). Fecal microbiota transplantation (FMT) is more effective than antibiotics in treating recurrent CDI, but its efficacy in preventing CDI-related BSI is uncertain. ⋯ None.